A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
Study Summary
The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care
Lead SponsorAscendis Pharma Endocrinology Division A/S
Data Retrieved2026-04-11 02:54:40.919387+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.